Investor Relations

Corporate Profile

REVA Medical, Inc. ("REVA" or the "Company") is a pre-revenue medical device company that is working to commercialize its proprietary bioresorbable scaffolds, as an alternative to metal stents, to treat coronary artery disease. Scaffolds provide restoration of blood flow, support the artery through the healing process, then disappear (or “resorb”) from the body over a period of time. This resorption allows the return of natural movement and function of the artery, a result not attainable with permanent metal stents...more »


Read More

Recent News

Appendix 4C - quarterly
Appendix 3B
REVA to Present at TCT 2016
View all

Featured Documents

Email Alerts

Sign up to receive the latest financial news and events by email.

Sign up for alerts